Nuclear factor of activated T cells (NFAT) as a molecular target for 1α,25-dihydroxyvitamin D3-mediated effects

Journal of Immunology

Volumn 160, Issue 1, 1998, Pages 209-218

  Takeuchi, Atsuko ^a   Reddy, G Satyanarayana ^a   Kobayashi, Tadashi ^b   Okano, Toshio ^b   Park, Jungchan ^a,c   Sharma, Surendra ^a  

^a BROWN UNIVERSITY   (United States)

^b KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^c Hankuk University of Foreign Studies   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; COLECALCIFEROL; CYTOKINE; INTERLEUKIN 2; RETINOID X RECEPTOR; TRANSCRIPTION FACTOR; VITAMIN RECEPTOR;

ARTICLE; DNA BINDING; GENE EXPRESSION; GENETIC TRANSCRIPTION; HORMONE ACTION; HUMAN; HUMAN CELL; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; PROTEIN BINDING; T LYMPHOCYTE;

BASE SEQUENCE; BINDING SITES; CALCITRIOL; DIMERIZATION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-2; JURKAT CELLS; LYMPHOCYTE ACTIVATION; NFATC TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); RECEPTORS, CALCITRIOL; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; T-LYMPHOCYTES; TONSIL; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0031883711     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (75)

1. Reichel, H., H. P. Koeffler, and A. W. Norman. 1989. The role of the vitamin D endocrine system in health and disease. N. Engl. J. Med. 320:980.
2. Darwish, H., and H. F. DeLuca. 1993. Vitamin D-regulated gene expression. Crit. Rev. Eukaryotic Gene Exp. 3:89.
3. Walters, M. R. 1992. Newly identified actions of the vitamin D endocrine system. Endocrinol. Rev. 13:719.
4. Nemere, I., and A. W. Norman. 1991. Steroid hormone actions at the plasma membrane: induced calcium uptake and exocytotic events. Mol. Cell. Endocrinol. 80:C165.
5. 3. J. Biol. Chem. 268:20022.
6. Haussler, M. R. 1986. Vitamin D Receptors: nature and function. Annu. Rev. Nutr. 6:527.
7. 3 receptors: Structure and function in transcription. Annu. Rev. Nutr. 11:189.
8. Mangelsdorf, D. J., C. Thummel, M. Beato, P. Herrlich, G. Schutz, K. Umesono, B. Blumberg, P. Kastner, M. Mark, P. Chambon, and R. M. Evans. 1995. The nuclear receptor superfamily: The second decade. Cell 83:835.
9. 3-receptors. Cell 65:1255.
10. 3 signaling pathways. J. Biol. Chem. 268:17830.
11. Yu, V. C., C. Delsert, B. Andersen, J. M. Holloway, O. V. Devary, A. M. Naar, S. Y. Kim, J. M. Boutin, C. K. Glass, and M. G. Rosenfeld. 1991. RXR beta: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell 67:1251.
12. Bugge, T. H., J. Pohl, O. Lonnoy, and H. G. Stunnenberg. 1992. RXRα, promiscuous partner of retinoic acid and thyroid hormone receptors. EMBO J. 11:1409.
13. 3 signaling. Nature 355:446.
14. 3. Mol. Endocrinol. 9:1814.
15. 3 are associated with enhanced activation of the vitamin D receptor. J. Biol. Chem. 270:10551.
16. Staal, A., A. J. van Wijnen, J. C. Birkenhager, H. A. P. Pols, J. Prahl, H. DeLuca, M.-P. Gaub, J. B. Lian, G. S. Stein, J. P. T. M. van Leeuwen, and J. L. Stein. 1996. Distinct conformations of vitamin D receptor/retinoid X receptor-α heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes. Mol. Endocrinol. 10:1444.
17. 3 inhibits osteocalcin expression in mouse through indirect mechanism. J. Biol. Chem. 272:110.
18. 3: a novel immunoregulatory hormone. Science 224:1438.
19. Rigby, W. F. C. 1988. The immunology of vitamin D. Immunol. Today 9:54.
20. 3. J. Cell Biochem. 49:26.
21. Yang, S., C. Smith, J. M. Prahl, X. Luo, and H. F. DeLuca. 1993. Vitamin D deficiency suppresses cell-mediated immunity in vivo. Arch. Biochem. Biophys. 303:98.
22. 3. Proc. Natl. Acad. Sci. USA 78:4990.
23. 3. Proc. Natl. Acad. Sci. USA 80:5907.
24. 3 induces the maturation of the human monocyte cell line U937, and, in association with a factor from human T lymphocytes, augments production of the monokine, mononuclear cell factor. J. Clin. Invest. 73:731.
25. 3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells. J. Cell Biol. 98:391.
26. 3-induced terminal monocytic differentiation of human leukemic cell lines. J. Immunol. 150:2418.
27. 3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J. Clin. Endocrinol. Metab. 57:1308.
28. 3 (calcitriol). J. Clin. Invest. 74:1451.
29. 3-mediated gene regulation in human B lymphocytes. J. Biol. Chem. 269:13437.
30. 3 inhibits antigen-induced T cell activation. J. Immunol. 133:1748.
31. 3 on human T lymphocyte activation and proliferation: a cell cycle analysis. J. Immunol. 135:2279.
32. 3 suppresses human T helper/inducer lymphocyte activity in vitro. J. Immunol. 134:3032.
33. 3-regulated expression of genes involved in human T-lymphocyte proliferation and differentiation. Cancer Res. 46:5827.
34. 3. J. Clin. Invest. 79:1659.
35. 3 inhibits interferon-γ synthesis by normal human peripheral blood lymphocytes. Proc. Natl. Acad. Sci. USA 84:3385.
36. 3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J. Clin. Invest. 87:1103.
37. 3 prevents insulitis in NOD mice. Diabetes 41:1491.
38. 3, exerts immunosuppressive activity equal to its parent without causing hypercalcemia in vivo. Endocrinology 135:2818.
39. Branisteanu, D. D., C. Mathieu, K. Casteels, and R. Bouillon. 1996. Combination of vitamin D analogs and immunosuppressants; potential clinical use. Clin. Immunother. 6:465.
40. Schwartz, R. H. 1992. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71:1065.
41. Fraser, J. D., D. Straus, and A. Weiss. 1993. Signal transduction events leading to T-cell lymphokine gene expression. Immunol. Today 14:357.
42. Crabtree, G. R., and N. A. Clipstone. 1994. Signal transmission between the plasma membrane and nucleus of T lymphocytes. Annu. Rev. Biochem. 63:1045.
43. Fujita, T., H. Shibuya, T. Ohashi, K. Yamanishi, and T. Taniguchi. 1986. Regulation of human interleukin-2 gene: functional DNA sequences in the 5′ flanking region for the gene expression in activated T lymphocytes. Cell 46:401.
44. Durand, D. B., M. R. Bush, J. G. Morgan, A. Weiss, and G. R. Crabtree. 1987. A 275 basepair fragment at the 5′ end of the interleukin-2 gene enhances expression from a heterologous promoter in response to signals from the T cell antigen receptor. J. Exp. Med. 165:395.
45. Serfling, E., A. Avots, and M. Neumann. 1995. The architecture of the interleukin-2 promoter: a reflection of T lymphocyte activation. Biochim. Biophys. Acta 1263:181.
46. 3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol. Cell. Biol 15:5789.
47. 3. Proc. Natl. Acad. Sci. USA 92:10990.
48. Vacca, A., M. P. Felli, A. R. Farina, S. Martinotti, M. Maroder, I. Screpanti, D. Meco, E. Petrangeli, L. Frati, and A. Gulino. 1992. Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements. J. Exp. Med. 175:637.
49. Scheinman, R. I., P. C. Cogswell, A. K. Lofquist, and A. S. Baldwin, Jr. 1995. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 270:283.
50. Auphan, N., J. A. DiDonato, C. Rosette, A. Helmberg, and M. Karin. 1995. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 270:286.
51. Rao, A. 1994. NFATp: a transcription factor required for the co-ordinate induction of cytokine genes. Immunol. Today 15:274.
52. Jain, J., P. G. McCafferey, Z. Miner, T. K. Kerppola, J. N. Lambert, G. L. Verdine, T. Curran, and A. Rao. 1993. Nuclear factor of activated T cells contains Fos and Jun. Nature 365:352.
53. Lyakh, L., P. Ghosh, and N. R. Rice. 1997. Expression of NFAT-family proteins in normal human T cells. Mol. Cell. Biol. 17:2475.
54. Yaseen, N. R., J. Park, T. Kerppola, T. Curran, and S. Sharma. 1994. A central role for Fos in human B-and T-cell NFAT (nuclear factor of activated T cells): an acidic region is required for in vitro assembly. Mol. Cell. Biol. 14:6886.
55. Park, J., N. R. Yaseen, P. G. Hogan, A. Rao, and S. Sharma. 1995. Phosphorylation of the transcription factor NFATp inhibits its DNA binding activity in cyclosporin A-treated human B and T cells. J. Biol. Chem. 270:20653.
56. Shaw, K. T.-Y., A. M. Ho, A. Raghavan, J. Kim, J. Jain, J. Park, S. Sharma, A. Rao, and P. G. Hogan. 1995. Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells. Proc. Natl. Acad. Sci. USA 92:11205.
57. Luo, C., K. T.-Y. Shaw, A. Raghavan, J. Aramburu, F. Garcia-Cozar, B. A. Perrino, P. G. Hogan, and A. Rao. 1996. Interaction of calcineurin with a domain of the transcription factor NFAT 1 that controls nuclear import. Proc. Natl. Acad. Sci. USA 93:8907.
58. Shibasaki, F., E. R. Price, D. Milan, and F. McKeon. 1996. Role of kinases and the phosphatase calcineurin in the nuclear shuttling of transcription factor NF-AT4. Nature 382:370.
59. 2+ signals and immunosuppression. Nature 383:837.
60. Rooney, J. W., Y.-L. Sun, L. H. Glimcher, and T. Hoey. 1995. Novel NFAT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation. Mol. Cell. Biol. 15:6299.
61. Park, J., A. Takeuchi, and S. Sharma. 1996. Characterization of a new isoform of the NFAT (nuclear factor of activated T cells) gene family member NFATc. J. Biol. Chem. 271:20914.
62. Yaseen, N. R., A. L. Maizel, F. Wang, and S. Sharma. 1993. Comparative analysis of NFAT (nuclear factor of activated T cells): complex in human T and B lymphocytes. J. Biol. Chem. 268:14285.
63. 3-activated expression of the rat osteocalcin gene. Mol. Cell. Biol. 13:5907.
64. Carlberg, C., I. Bendik, A. Wyss, E. Meier, L. J. Sturzenbecker, J. F. Grippo, and W. Hunziker. 1993. Two nuclear signalling pathways for vitamin D. Nature 361:657.
65. Peterson, B., L. J. Sun, and G. L. Verdine. 1996. A critical arginine residue mediates cooperation in the contact interface between transcription factors NFAT and AP-1. Proc Natl. Acad Sci. USA 93:13671.
66. Tsai, M. J., and B. W. O'Malley. 1994. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63:451.
67. 3-and butyrate-inducible responses. Proc. Natl. Acad. Sci. USA 90:2984.
68. 3 receptor and other nonreceptor transcription factors. Mol. Endocrinol. 8:1593.
69. McCaffrey, P. G., C. Luo, T. K. Kerppola, J. Jain, T. M. Badalian, A. M. Ho, E. Burgeon, W. S. Lane, J. N. Lambert, T. Curran, G. L. Verdine, A. Rao, and P. G. Hogan. 1993. Isolation of the cyclosporin-sensitive T cell transcription factor NFATp. Science 262:750.
70. Northrop, J. P., S. N. Ho, L. Chen, D. J. Thomas, L. A. Timmerman, G. P. Nolan, A. Admon, and G. R. Crabtree. 1994. NF-AT components define a family of transcription factors targeted in T-cell activation. Nature 369:497.
71. Hoey, T., Y.-L. Sun, K. Williamson, and X. Xu. 1995. Isolation of two new members of the NF-AT gene family and functional characterization of NF-AT proteins. Immunity 2:461.
72. Masuda, E. S., Y. Naito, H. Tokumitsu, D. Campbell, F. Saito, C. Hannum, K.-I. Arai, and N. Arai. 1995. NFATx, a novel member of the nuclear factor of activated T cells family that is expressed predominantly in the thymus. Mol. Cell. Biol. 15:2697.
73. 3. J. Neuroimmunol. 61:151.
74. 3 on the induction of experimental autoimmune thyroiditis. Clin. Immunol. Immunopath. 54:53.
75. 3) and its analogs are dose-reducing agents for cyclosporin A in vitro and in vivo. Transplant. Proc. 26:3048.